Log in Book a Demo

US Pharma & Biotech Pulmonology - PPC Market Share Analysis March 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pulmonology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pulmonology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
copdfoundation.org 26.42
resphealth.org 12.16
dupixenthcp.com 11.37
breztrihcp.com 7.94
geneticcopdtest.com 6.63
dupixent.com 6.46
tezspire.com 5.24
airsupra.com 4.02
breztri.com 3.54
dukehealth.org 2.88
others 13.34

Copyright © Adthena. All rights reserved.

In the PPC landscape, copdfoundation.org leads with 26.42% click share, while ‘others’ collectively hold 13.34%, showcasing diverse advertiser presence.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pulmonology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date tezspire.com airsupra.com dupixent.com pulmonx.com copdfoundation.org resphealth.org geneticcopdtest.com breztrihcp.com breztri.com dupixenthcp.com
2025/03/01 13.29% 5.84% 2.35% 1.8% 0.88% 0% 0% 13.61% 25.79% 4.09%
2025/03/02 19.26% 14.5% 0% 3.75% 1.88% 0% 0% 3.57% 14.12% 3.03%
2025/03/03 1.95% 1.82% 4.66% 0.95% 0.37% 0% 0% 7.26% 53.27% 2.19%
2025/03/04 15.81% 4.12% 6.37% 1.76% 0.98% 0% 0% 5.68% 14.86% 6.73%
2025/03/05 11.22% 18.93% 0.81% 17.26% 6.31% 0% 0% 0.21% 1.67% 20.78%
2025/03/06 4.17% 0.83% 12.51% 1.61% 54.41% 0% 0% 1.97% 0.11% 2.38%
2025/03/07 16.61% 7.69% 3.9% 4.51% 1.34% 0% 0% 13.64% 5.19% 7.2%
2025/03/08 11.27% 8.8% 1.57% 2.2% 0.04% 46.84% 0% 11.07% 0.35% 5.53%
2025/03/09 1.7% 0.89% 74.67% 5.76% 0.11% 0% 0% 4.14% 0.2% 7.42%
2025/03/10 10.11% 5.75% 3.36% 2.12% 0.03% 14.55% 0% 28.4% 0.04% 25.87%
2025/03/11 5.02% 1.77% 0.31% 3.04% 0.03% 0% 49.54% 37.96% 0.04% 0%
2025/03/12 12.84% 4.43% 0.68% 3.32% 68.81% 0% 0% 6.55% 0.02% 0%
2025/03/13 3.98% 1.32% 0.7% 2.15% 25.99% 32.02% 0% 3.71% 0.01% 25.49%
2025/03/14 3.52% 1.23% 35.58% 1.97% 0.01% 0% 0% 16.21% 0.01% 37.13%
2025/03/15 8.96% 1.34% 1.49% 4.23% 75.79% 0% 0% 0.44% 0% 0%
2025/03/16 1.22% 0.33% 2.06% 2.35% 31.42% 0% 0% 0.15% 0% 31.01%
2025/03/17 41.19% 4.02% 15.33% 20.32% 2.62% 0% 0% 1.32% 0% 1.7%
2025/03/18 1.78% 0.11% 0.09% 1.22% 19.43% 18.43% 36.63% 0.05% 0% 20.3%
2025/03/19 14.15% 15.77% 0.16% 31.81% 0.1% 2.64% 0% 0.84% 0% 0%
2025/03/20 25.48% 21.78% 18.49% 14.05% 1.76% 0% 0% 0.16% 0% 0%
2025/03/21 30.25% 29.52% 2.3% 14.56% 0.02% 0% 0% 0.08% 0% 1.42%
2025/03/22 2.85% 4.38% 0.19% 4.31% 0.01% 69.58% 0% 4.06% 3.75% 0%
2025/03/23 0.06% 2.25% 4.27% 1.58% 86.81% 0% 0% 0% 0% 0%
2025/03/24 13.61% 14.79% 1.67% 45.47% 0.05% 0% 0% 0% 0% 0%
2025/03/25 21.1% 16.33% 0% 11.01% 2.11% 0% 0% 0% 0% 1.61%
2025/03/26 37.51% 19.64% 4.55% 2.57% 0% 0% 0% 0% 0% 0%
2025/03/27 16.24% 15.1% 1.58% 1.04% 0% 0% 0% 0% 0% 0.99%
2025/03/28 41.04% 38.57% 0% 1.06% 0% 0% 0% 0% 0% 0%
2025/03/29 36.21% 32.76% 0% 1.06% 0% 0% 0% 0% 0% 2.68%
2025/03/30 2.26% 5.1% 0.32% 0.33% 84.14% 0% 0% 0% 0% 0%
2025/03/31 37.39% 31.12% 2.59% 0.91% 0% 0% 0% 0% 0% 0%

Copyright © Adthena. All rights reserved.

In March 2025, copdfoundation.org saw significant fluctuations, peaking at 86.81% on March 23. Meanwhile, tezspire.com maintained steady activity, with a notable spike on March 28 at 41.04%. The month concluded with copdfoundation.org leading the spend share.

Market Exposure

Competitor Count for US Pharma & Biotech Pulmonology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/03/01 47
2025/03/02 42
2025/03/03 47
2025/03/04 42
2025/03/05 43
2025/03/06 47
2025/03/07 42
2025/03/08 51
2025/03/09 36
2025/03/10 47
2025/03/11 32
2025/03/12 27
2025/03/13 31
2025/03/14 27
2025/03/15 25
2025/03/16 26
2025/03/17 27
2025/03/18 35
2025/03/19 34
2025/03/20 39
2025/03/21 40
2025/03/22 34
2025/03/23 31
2025/03/24 31
2025/03/25 22
2025/03/26 24
2025/03/27 26
2025/03/28 19
2025/03/29 23
2025/03/30 21
2025/03/31 26

Copyright © Adthena. All rights reserved.

March began with 47 advertisers, fluctuating throughout. Mid-month saw a dip to 25, but it rebounded to 26 by month’s end.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pulmonology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
airsupra.com 6.48%
copdfoundation.org 5.56%
geneticcopdtest.com 5.25%
resphealth.org 4.63%
tezspire.com 3.29%
dukehealth.org -3.71%
simplyhealth.io -3.71%
dupixenthcp.com -5.21%
dupixent.com -6.96%
breztrihcp.com -10.22%

Copyright © Adthena. All rights reserved.

Airsupra.com soared with a 6.48% click share increase, while breztrihcp.com plummeted by 10.22%.

Campaign Efficiency

US Pharma & Biotech Pulmonology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date airsupra.com tezspire.com dupixent.com chroniclungdiseases.com copdfoundation.org resphealth.org simplyhealth.io geneticcopdtest.com breztrihcp.com dupixenthcp.com
2025/03/01 8.09% 14.08% 2.53% 0% 0.95% 0% 0% 0% 13.83% 2.39%
2025/03/02 22.71% 24% 0% 0% 1.31% 0% 0% 0% 2.81% 0.74%
2025/03/03 2.82% 1.68% 2.31% 0% 0.32% 0% 0% 0% 7.19% 1.05%
2025/03/04 4.41% 21.52% 1.13% 0% 1.26% 0% 0% 0% 5.03% 3.15%
2025/03/05 45.92% 10.41% 0.96% 0% 5.43% 0% 0% 0% 0.16% 7.17%
2025/03/06 2.21% 5.14% 17.27% 0% 51.59% 0% 0% 0% 2.05% 0.73%
2025/03/07 10.46% 18.57% 4.14% 0% 1.03% 0% 0% 0% 16.28% 2.3%
2025/03/08 13.31% 14.4% 1.73% 0.18% 0.05% 42.24% 0% 0% 13.1% 1.94%
2025/03/09 0.67% 1.54% 85.51% 0% 0.11% 0% 0% 0% 2.97% 2.3%
2025/03/10 7.92% 11.27% 3.19% 0% 0.03% 21.54% 0% 0% 26.29% 22.27%
2025/03/11 1.78% 4.54% 0.27% 0% 0.03% 0% 0% 59.21% 31.05% 0%
2025/03/12 5.91% 15.02% 0.66% 0% 68.05% 0% 0% 0% 5.89% 0%
2025/03/13 1.85% 2.56% 0.46% 29.78% 14.97% 29.78% 0% 0% 2.15% 14.95%
2025/03/14 3.35% 3.3% 29.35% 0% 0% 0% 0% 0% 28.99% 28.53%
2025/03/15 1.25% 10.81% 1.4% 0.34% 78.4% 0% 0% 0% 0.37% 0%
2025/03/16 0.35% 1.1% 2.13% 0% 30.65% 0% 30.65% 0% 0.12% 30.78%
2025/03/17 4.64% 49.68% 14.1% 0% 1.87% 0% 0% 0% 0.95% 1.42%
2025/03/18 0.19% 2.52% 0.17% 0% 18.99% 18.98% 18.98% 18.98% 0.04% 18.98%
2025/03/19 34.27% 9.45% 0.14% 0% 0.09% 1.13% 0% 0% 0.55% 0%
2025/03/20 27.07% 27.21% 22.74% 0.9% 0.93% 0% 0% 0% 0.1% 0%
2025/03/21 38.45% 35.69% 2.13% 0% 0.02% 0% 0% 0% 0.04% 1.06%
2025/03/22 9.84% 2.33% 0.23% 0% 0.01% 64.74% 0% 0% 4.75% 0%
2025/03/23 3.78% 0.05% 2.1% 44.33% 44.34% 0% 0% 0% 0% 0%
2025/03/24 24.06% 12.78% 1.95% 0% 0.08% 0% 0% 0% 0% 0%
2025/03/25 31.08% 20.77% 0% 0% 1.51% 0% 0% 0% 0% 1.23%
2025/03/26 36.6% 32.76% 2.55% 0.05% 0% 0% 0% 0% 0% 0%
2025/03/27 36.16% 19.38% 1.86% 0.04% 0% 0% 0% 0% 0% 0.93%
2025/03/28 42.42% 40.84% 0% 0.03% 0% 0% 0% 0% 0% 0%
2025/03/29 46.15% 31.11% 0% 0.03% 0% 0% 0% 0% 0% 1.64%
2025/03/30 11.34% 1.49% 0.35% 0.03% 79.89% 0% 0% 0% 0% 0%
2025/03/31 37.72% 37.44% 1.66% 0.07% 0% 0% 0% 0% 0% 0%

Copyright © Adthena. All rights reserved.

March saw dramatic shifts in PPC impressions. COPD Foundation peaked mid-month, while Airsupra and Tezspire surged late March. Dupixent’s early spike was notable. The month concluded with Airsupra leading.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Treating COPD Patients? Prescription treatment website

    HCPs: Request Samples — Physicians: See How This COPD Treatment Option May Help Reduce Exacerbations In Patients.

  2. 2
    COPD Treatment At Home - 92% of Patients Breathe better https://get.cardahealth.com › online › pulmonary-rehab

    Join the pulmonary rehabilitation program that's changing the lives of seniors nationwide.

  3. 3
    COPD Treatment Options https://www.dukehealth.org › lung-disease › copd

    COPD Tests & Treatments — Imagine a Life Without Limits. What Would Your Life Look Like After Lung Transplant?

  4. 4
    Official HCP Website - A Medication Option - COPD Lung Disease Prescription treatment website

    HCPs: Expand Your Treatment Plans With An Add-On Option For Triple Therapy Patients.

  5. 5
    Understanding COPD - Living with COPD - Signs of COPD https://www.resphealth.org › copd

    Chronic obstructive pulmonary disease causes difficulty breathing and shortness of breath. 16 million Americans have been diagnosed...

Copyright © Adthena. All rights reserved.

In the competitive landscape of COPD treatment, advertisers like Breztri and Dupixent focus on healthcare professionals, emphasizing sample requests and treatment expansion. Carda Health and Duke Health highlight transformative patient experiences, while Resp Health educates on COPD’s impact, reaching 16 million Americans.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.